Women receiving news of a family BRCA1/2 mutation: messages of fear and empowerment
- PMID: 21091619
- DOI: 10.1111/j.1547-5069.2010.01366.x
Women receiving news of a family BRCA1/2 mutation: messages of fear and empowerment
Abstract
Purpose: Communication of genetic test results to healthy at-risk family members is complicated considering family dynamics and the complexity of cancer genetics. The purpose of this study was to understand the experience of family communication of BRCA1/2 results from the perspective of young and middle-aged women receiving the news. THEORETICAL RATIONALE: Individuals are self-interpretive beings influenced by family culture, history, and communication patterns. Humans express meaning through language and stories.
Methods: Heideggerian hermeneutics guided in-depth interviews and team interpretation of data. Using purposive and network sampling, 19 women 18 to 50 years of age who received news of a family BRCA1/2 mutation from a biologic relative were recruited from support groups and two health facilities in upstate New York.
Findings: Five themes emerged: (a) situating the story, (b) receiving the message from family, (c) responding to receipt of the message, (d) impacting family communication, and (e) advice for communicating risk. Two constitutive patterns were identified: (a) communicating risk as a message of fear and empowerment and (b) integrating the message by taking one step at a time.
Conclusions/implications: Healthcare professionals (HCPs) have an important role in provision of anticipatory guidance for communication of genetic test results, including the potential behavioral and emotional responses to family risk communication. Future research is indicated to understand the role of HCPs in family risk communication.
Clinical relevance: Presentation of comprehensive and balanced information and the use of patient-centered communication is essential. HCPs need to view women as whole rather than as a person at risk. Continued support is needed for women who subsequently test positive or negative for the family BRCA1/2 mutation from HCPs and others, often outside the family network.
© 2010 Sigma Theta Tau International.
Comment in
-
Impact of the genetic screening revolution: understanding and meeting the needs of previvors with a known family mutation in BRCA/BRCA2.Evid Based Nurs. 2011 Oct;14(4):126-7. doi: 10.1136/ebn1168. Epub 2011 Jun 6. Evid Based Nurs. 2011. PMID: 21646380 No abstract available.
Similar articles
-
Learning about a twist in the road: perspectives of at-risk relatives learning of potential for cancer.Oncol Nurs Forum. 2010 Nov;37(6):723-33. doi: 10.1188/10.ONF.723-733. Oncol Nurs Forum. 2010. PMID: 21059584
-
Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.Patient Educ Couns. 2007 Jan;65(1):58-68. doi: 10.1016/j.pec.2006.05.006. Epub 2006 Jul 26. Patient Educ Couns. 2007. PMID: 16872788
-
Cancer Risk Information Sharing: The Experience of Individuals Receiving Genetic Counseling for BRCA1/2 Mutations.J Health Commun. 2017 Feb;22(2):143-152. doi: 10.1080/10810730.2016.1258743. Epub 2017 Jan 23. J Health Commun. 2017. PMID: 28112991 Free PMC article.
-
BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses.J Am Acad Nurse Pract. 2005 Dec;17(12):518-26. doi: 10.1111/j.1745-7599.2005.00091.x. J Am Acad Nurse Pract. 2005. PMID: 16293160 Review.
-
[Cognitive, emotional and behavioral impact of an uncertain outcome after study of BRCA1/2: review of the literature].Bull Cancer. 2011 Feb;98(2):184-98. doi: 10.1684/bdc.2011.1309. Bull Cancer. 2011. PMID: 21382771 Review. French.
Cited by
-
Living With Genetic Vulnerability: a Life Course Perspective.J Genet Couns. 2016 Feb;25(1):49-61. doi: 10.1007/s10897-015-9877-x. Epub 2015 Sep 2. J Genet Couns. 2016. PMID: 26323596
-
Understanding the Needs of Young Women Regarding Breast Cancer Risk Assessment and Genetic Testing: Convergence and Divergence among Patient-Counselor Perceptions and the Promise of Peer Support.Healthcare (Basel). 2016 Jun 28;4(3):35. doi: 10.3390/healthcare4030035. Healthcare (Basel). 2016. PMID: 27417623 Free PMC article.
-
Development and Testing of a Decision Aid for Unaffected Women with a BRCA1 or BRCA2 Mutation.J Cancer Educ. 2020 Apr;35(2):339-344. doi: 10.1007/s13187-019-1470-9. J Cancer Educ. 2020. PMID: 30661232
-
Seeking balance: decision support needs of women without cancer and a deleterious BRCA1 or BRCA2 mutation.J Genet Couns. 2014 Jun;23(3):350-62. doi: 10.1007/s10897-013-9667-2. Epub 2013 Nov 22. J Genet Couns. 2014. PMID: 24271037 Free PMC article.
-
Life events may contribute to family communication about cancer risk following BRCA1/2 testing.J Genet Couns. 2013 Apr;22(2):249-57. doi: 10.1007/s10897-012-9531-9. Epub 2012 Aug 15. J Genet Couns. 2013. PMID: 22892900
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous